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Background: Exercise-based cardiac rehabilitation increases peak oxygen uptake (peak VO2), which is an impor-
tant predictor of mortality in cardiac patients. However, it remains unclear which exercise characteristics are
most effective for improving peak VO2 in coronary artery disease (CAD) patients. Proof of concept papers com-
paring Aerobic Interval Training (AIT) andModerate Continuous Training (MCT)were conducted in small sample
sizes and ﬁndings were inconsistent and heterogeneous. Therefore, we aimed to compare the effects of AIT and
Aerobic Continuous Training (ACT) on peak VO2, peripheral endothelial function, cardiovascular risk factors,
quality of life and safety, in a large multicentre study.
Methods: Two-hundred CAD patients (LVEF N40%, 90% men, mean age 58.4 ± 9.1 years) were randomized
to a supervised 12-week cardiac rehabilitation programme of three weekly sessions of either AIT
(90–95% of peak heart rate (HR)) or ACT (70–75% of peak HR) on a bicycle. Primary outcome was peak
VO2; secondary outcomes were peripheral endothelial function, cardiovascular risk factors, quality of
life and safety.
Results: Peak VO2 (ml/kg/min) increased signiﬁcantly in both groups (AIT 22.7 ± 17.6% versus ACT 20.3 ±
15.3%; p-time b 0.001). In addition, ﬂow-mediated dilation (AIT +34.1% (range –69.8 to 646%) versus
ACT +7.14% (range –66.7 to 503%); p-time b 0.001) quality of life and some other cardiovascular risk fac-
tors including resting diastolic blood pressure and HDL-C improved signiﬁcantly after training. Improve-
ments were equal for both training interventions.
Conclusions: Contrary to earlier smaller trials, we observed similar improvements in exercise capacity and
peripheral endothelial function following AIT and ACT in a large population of CAD patients.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).liability and freedom from bias of the data presented and their discussed interpretation.
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Coronary artery disease (CAD) is themain cause of death worldwide
[1] and in Europe [2]. The beneﬁts of exercise-based cardiac rehabilita-
tion on cardiovascular risk factors [3,4], on quality of life (QoL) [5], on
exercise tolerance (peak VO2) [6–9], and on cardiacmorbidity andmor-
tality [3,4] have been widely established in CAD patients. However,
there is still controversy regarding the optimal exercise characteristics
that yield the most beneﬁcial effects in patients with CAD [10,11]. The
“traditional” approach is to prescribe training at an intensity of 60 to
80% of peak VO2, which results in an average increase of 20% for peak
VO2 [12]. Intensity seems to be an important predictor of the effective-
ness of cardiac rehabilitation programmes since a higher intensity
leads to larger improvements in peak VO2, even after adjustment for
other training-related variables [12,13]. However, a higher intensity is
difﬁcult to maintain for a longer period; therefore an interval structure
is suggested by Mezzani et al. [11]. Interval training consists of periods
of high-intensity exercise alternated by periods of relative rest that
makes it possible for patients to complete short work periods at higher
intensities. From a physiological point of view, high intensity interval
training stimulates cardiac contractility and poses a larger impact on
the endothelium and skeletal muscle mitochondrial function compared
to continuous training atmoderate intensity (MCT), which could add to
amore favourable effect on peakVO2 [14].Whereas the implementation
of high intensity aerobic interval training (AIT) is common practice
in sports medicine, only relatively small, single centre trials have
tested this approach in CAD patients [15,16]. A recent meta-analysis,
comprising 9 studies and 206 patients, concluded that AIT results in a
1.60 ml/kg/min larger beneﬁt in peak VO2 compared toMCT in patients
with CAD [16]. The AIT group showed an improvement of 20.5% in peak
VO2 compared to only 12.8% in the MCT group, the latter being low
compared to the average increases after three months of “traditional”
cardiac rehabilitation [12]. Given the small sample sizes and the large
inconsistency and heterogeneity between the study results, this meta-
analysis highly recommended that a sufﬁciently powered randomized
multicentre study is warranted to 1) assess efﬁcacy and safety of AIT
[16], and to 2) investigate if the aerobic continuous training (ACT) can
be performed at intensities higher than 70–75% of peak heart rate
(HR) resulting in better improvements.
Therefore, the aim of the present study [17] was to assess whether a
12-week programme of three weekly, supervised sessions of AIT is
superior to aerobic continuous training (ACT) in terms of 1) peak VO2,
2) peripheral endothelial function, 3) cardiovascular risk factors,
4) QoL and 5) safety.
2. Methods
A detailed description of study design, eligibility and participants of the Study on
Aerobic INTerval EXercise training in CAD patients (SAINTEX-CAD) has been published
previously [17].
2.1. Participants
Two hundred CAD patients (aged between 40–75 years) referred for cardiac rehabil-
itation were enrolled in a longitudinal, randomized prospective clinical study at the Uni-
versity Hospital of Antwerp (Centre 1) and the University Hospital of Leuven (Centre 2),
100 patients at each site. Inclusion criteria were: [17] 1) angiographically documented
CAD or previous acute myocardial infarction (AMI), 2) left ventricular ejection fraction
(LVEF) N40%, 3) on optimal medical treatment, 4) stable with regard to symptoms and
medication for at least 4 weeks and 5) included between 4 and 12 weeks following
AMI, Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting
(CABG). After obtaining written informed consent, patients were randomized to AIT or
ACT on a 1:1 base. The study complied with the World Medical Association Declaration
ofHelsinki on ethics inmedical research [18] andwas approvedby the localmedical ethics
committees.
2.2. Measurements
Anthropometric measurements, echocardiography and blood analyses were
performed at baseline and after 12 weeks. The cardiopulmonary exercise test (CPET),ﬂow-mediated dilation (FMD) and QoL were assessed at baseline, 6 weeks and
12 weeks. The CPET at 6 weeks was performed to adjust the training intensity according
to the achieved peak HR.
2.2.1. Anthropometric measurements
Height (cm) and weight (kg) were measured before the CPET using a stadiometer
(Seca model) and a scale (Centre 1, ADE; Centre 2, Tefal, Sensitive Computer). Body
mass index (BMI) was calculated as the weight (kg) over the height squared (m2).
Waist circumference (cm) was measured end-expiratory at a level midway between the
lowest rib and the iliac crest.
2.2.2. Cardiopulmonary exercise test
As described previously [17], a maximal graded exercise test (20 W+ 20 W/min or
10W+ 10 W/min) on a bicycle ergometer was performed. Twelve-lead ECG and gas ex-
change measurements were recorded continuously, and blood pressure was measured
every 2 min. Peak VO2 was determined as the mean value of VO2 during the ﬁnal 30 s of
exercise.
2.2.3. Flow-mediated dilation by brachial artery ultrasound scanning
Endothelium-dependent and -independent vasodilation of the right brachial artery
weremeasured by ultrasound scanning (Centre 1, AU5 Ultrasound System, Esaote; Centre
2, GEHealthcare, Vivid 7), in standardized conditions as described in the guidelines [19]. A
high resolution linear-array vascular probe was used (Centre 1, 10 MHz; Centre 2, 5–
13 MHz). Patients were positioned supine with the right arm resting on an arm support;
the brachial artery was imaged above the antecubital fossa in the longitudinal plane.
Blood pressure was obtained after 10min of rest with an automated blood pressure mon-
itor (Omron M6). To determine the endothelium-dependent vasodilation, the forearm
was occluded for 5 min at a cuff pressure of at least 200 mm Hg or 60 mm Hg higher
than the resting systolic blood pressure. Images were continuously recorded before cuff
inﬂation for 1 min, and after cuff deﬂation for 3 min. Endothelium-independent vasodila-
tion was measured after administering 1 dose (0.4 mg) of nitroglycerine (Nitrolingual®
Pumpspray) sublingually. Images were continuously recorded from the 3rd until the 9th
minute after administering nitroglycerine. Images were analysed using edge-detection
software FMD-i by Flomedi (Flomedi, Brussels, Belgium). FMD and Nitroglycerine-
mediated dilation (NMD) were expressed as the change in post-stimulus diameter as a
percentage of the baseline diameter. Analyses were blinded in both study centres.
2.3. Echocardiography
Patients were examined by experienced cardiologists, at rest in the left lateral supine
position using an ultrasound machine (Centre 1, GE Healthcare, Vivid 7; Centre 2, GE
Healthcare, Vivid E9) and a 1.5–4.5 MHz probe. Left ventricular ejection fraction (LVEF)
was calculated using the biplane Simpson's method on the 4- and 2-chamber views
of the left ventricle. The average of these two measurements was used in the statistical
analysis. Analyses were blinded and were performed by one cardiologist (CDM).
2.3.1. Blood analyses
Venous blood samples were drawn after an overnight fast. Total cholesterol, serum
triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), and glucose were analysed by the biochemical laboratories using
standard procedures at both University Hospitals. High sensitivity C-reactive protein
(hs-CRP) was analysed using standard procedures in Centre 1 on all blood samples.
Laboratory personnel were blinded to treatment allocation.
2.3.2. Quality of life
The Short Form-12 (SF-12) was used as a generic health status measure [20] and
comprises a physical component summary (PCS) and a mental component summary
(MCS) that refer to self-reported physical and mental health status, respectively [21].
2.3.3. Safety
All adverse eventswere reported immediately to the project coordinating committees
(Safety Committee and Adverse Event Committee) composed of two independent
researchers for each committee. Adverse events were deﬁned as all-cause mortality,
hospitalization for cardiovascular disease, atrial tachycardia, atrial ﬁbrillation or frequent
ventricular arrhythmias.
2.4. Exercise training
The training intervention (Fig. 1) was previously described by Conraads et al. [17]. In
short, patients followed a supervised training programme3 times aweekduring12 weeks
of either AIT (90–95% of peakHR) or ACT (at least 70–75% of peakHR) on a bicycle (Centre
1, Technogym XT; Centre 2, Ergo-ﬁt, Gymna). Besides 36 exercise sessions, 6 additional
multi-disciplinary education sessions were organized.
Patients in Centre 1 exercised using a key, in which their target HR zones were pro-
grammed. The keywas connected to the bicycle, and workload was adapted continuously
according to the actual training HR. In Centre 2, a workload-based approach was used,
where workloads were determined for each training session, and HR was measured 4
times during each session. If the HR was no longer close to the upper border of the target
HR zone, the workload for the next session was adapted. The Borg 6–20 scale and blood
pressure were measured after each training session.
Fig. 1. Visual presentation of the AIT (A) and ACT (B) programme. a= 50–60% of peak VO2, 60–70% of peak heart rate, 11–13 Borg scale, no shortness of breath. b= 85–90% of peak VO2,
90–95% of peak heart rate, 15–17 Borg scale, shortness of breath. c = 50–70% of peak heart rate. d = at least 60–70% of peak VO2, at least 65–75% of peak heart rate.
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Data are presented as mean ± standard deviation (SD) or as number; in the ﬁgure
mean± standard error ofmeasurement (SEM)was used. All statistical analyseswere per-
formedusing SAS (SAS® 9.3, Sas Institute, Inc., Cary, NC,USA). Based on an effect size of 0.5
(increase in peak VO2 of 3.5 ml/kg/min, SD 7 ml/kg/min), we calculated that a total num-
ber of 172 patients would be needed to detect a larger beneﬁt with AIT, with a signiﬁcance
level of 0.05 and a statistical power of 0.90 [17]. To anticipate for potential drop-outs,
100 patients were enrolled in each treatment arm.
Baseline characteristics were calculated for the total group and the AIT and ACT group
separately. Groupdifferences anddifferences between inclusions andnon-inclusionswere
tested by ANOVA for continuous variables and by chi-square test for dichotomous vari-
ables. As there were group differences for age and pathology (AcuteMyocardial Infarction
(AMI), Coronary Artery Bypass Surgery (CABG), and Percutaneous Coronary Intervention
(PCI)) at baseline, an ANCOVA was performed to test the effects after 6 and 12 weeks of
training with age and pathology as covariates. Patients who had only AMI or AMI + PCI,
were categorized in the AMI group. The CABG group comprised all patients who had
CABG, AMI + CABG, or the combination of AMI + PCI + CABG. The PCI group consisted
of patients that only had PCI. The Scheffé test for multiple comparisons was used as a
post hoc test. Pearson correlation coefﬁcients were calculated between baseline values
and changes of the primary outcome peak VO2 (ml/kg/min) and secondary outcome
FMD (%).
For the primary and the secondary outcome (peak VO2 in ml/kg/min and FMD in %),
the effect of the centre of enrolment was calculated using an ANCOVA with centre as
covariate, in addition to age and pathology. No centre-effect was found for peak VO2
(p = 0.81) but FMD resulted in a signiﬁcantly higher mean value in Centre 2
(p b 0.001). Therefore, ANCOVA for FMD included age, pathology and centre as covariates.
Percentual changes of FMD were skewed and therefore expressed as median and range.
Intention-to-treat analysis [22], in which the results from all patients assigned to AIT
or ACT were taken into account, including drop-outs, was done for the primary outcome
(peak VO2 in ml/kg/min). The baseline data of the drop-outs were used as the missing
data at 6 and/or 12 weeks of the intervention. This intention-to-treat analysis usually re-
ﬂects the effects of treatment in everyday practice. As we aimed to investigate the results
of the treatment, we performed a per protocol analysis for the training effects.
All statistical tests were 2-sided at a signiﬁcance level of ≤0.05.
Mean training HRs and workloads for session 1 to 18 and 19 to 36 were calculated by
averaging the 4 HRs/workloads of each training session (AIT: HR/workload measured at
the end of each 4-minute interval; ACT: HR/workload measured at 10′, 20′, 30′ and 37′
of the moderate intensity bout) and dividing it by the number of training sessions
(=18). These mean HRs/workloads were expressed as % of the peak HR/workload of the
ﬁrst exercise test (peak HR 1/workload 1) for sessions 1–18 and of the second exercise
test (peak HR 2/workload 2) for sessions 19–36.
hs-CRP valueswere not detectable if b0.160mg/l and these valueswere thus replaced
by 0.160 mg/l. In addition, hs-CRP data were skewed and were therefore log transformed
before analyses.
3. Results
A ﬂowchart of the trial is presented in Fig. 2. One thousand thirty
seven patients were referred to cardiac rehabilitation betweenNovember 2010 and March 2013 (Centre 1, n = 392; Centre 2, n =
645). Four hundred seventy seven patients were eligible according to
the inclusion and exclusion criteria [17], of which 175 refused participa-
tion, 102 could not be included for other reasons, and 200 were ran-
domized to AIT or ACT. Age was not signiﬁcantly different (p = 0.23)
between the included patients (n = 200) and the eligible but non-
included patients (n = 277), respectively 58.4 ± 9.1 years versus
59.4 ± 8.9 years, but signiﬁcantly (p = 0.0035) less females were in-
cluded (included: 180 M and 20 F versus non-included: 222 M and
55 F): 45% of all men compared to 27% of all women participated.
Baseline characteristics of the included patients are presented in
Table 1. Age and pathology differed signiﬁcantly, with younger age,
more post-AMI and less post-PCI patients in the AIT group, while
other baseline values were similar between AIT and ACT.
As shown in Fig. 2, 26 patients dropped out (13%) during the
12 weeks of training, of which 15 from the AIT group (6 in Centre 1; 9
in Centre 2; NS) and 11 from the ACT group (5 in Centre 1; 6 in Centre
2; NS). The drop-out rate in women (7 out of 20; 5 AIT and 2 ACT)
was higher than the drop-out rate in men (19 out of 180; 10 AIT and 9
ACT; p = 0.002). According to previous calculations [17], a number
of 174 patients were still sufﬁcient to detect signiﬁcant differences
between AIT and ACT.
As shown in Table 2, peak VO2, peakworkload, peakHR andO2 pulse
increased signiﬁcantly over time (p b 0.001). Similar responses were
found after AIT and ACT. Peak VO2 increased with 14.5 ± 20.1% after
6 weeks and 22.7 ± 17.6% after 12 weeks of AIT; peak VO2 improved
with 13.1 ± 12.8% after 6 weeks and 20.3 ± 15.3% after 12 weeks of
ACT (Fig. 3). Results of the intention-to-treat analysis for peak VO2 did
not differ signiﬁcantly from the per protocol analysis.
We observed a signiﬁcant increase in FMD following training with no
difference between both training groups (Table 3). Flow-mediated dila-
tion increased with 12.3% (range –78.9 to 454%) after 6 weeks and 34.1%
(range –69.8 to 646%) after 12 weeks of AIT; FMD increased with 16.9%
(range –80.8 to 503%) after 6 weeks and 7.14% (range –66.7 to 503%)
after 12 weeks of ACT. Baseline FMDwas inversely correlatedwith chang-
es in FMD (r =−0.51; p b 0.001). Changes in peak VO2 (ml/kg/min)
correlated signiﬁcantly with changes in FMD (r = 0.17; p = 0.035).
As shown in Table 4, HDL-C and total cholesterol increased
signiﬁcantly after the 12-week intervention, with no difference be-
tween both training groups. Diastolic blood pressure and hs-CRP de-
creased signiﬁcantly over time, while systolic blood pressure tended
to decrease.
Fig. 2. Flowchart of the trial. n= number of patients; CAD= coronary artery disease; LVEF= left ventricular ejection fraction; AIT= aerobic interval training; ACT= aerobic continuous
training; F = female.
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domain following AIT and ACT, with no group differences (Table 4).
Increases from baseline to 6 weeks were signiﬁcant, with no further
signiﬁcant improvements from 6 to 12 weeks (data at 6 weeks not
shown).
Beta-blocker dose was changed in 32 patients during the interven-
tion period: the dose was doubled in 17 (5 AIT, 12 ACT) and halved in
8 (5 AIT, 3 ACT), stopped in 3 (1 AIT, 2 ACT) and started in 4 (2 AIT, 2
ACT) patients. When excluding these 32 patients, similar results were
found for all exercise- and endothelial-related variables, for cardiovas-
cular risk factors and QoL, except for resting diastolic blood pressure
(p-time N 0.05).
Overall compliance for the AIT group was 35.7 ± 1.1 training ses-
sions and for the ACT group 35.6 ± 1.5 training sessions. The analyses
of the training intensities were done for the total group of patients(n = 172), as it did not differ from the analyses excluding patients
changing their beta-blocker dose. Mean training intensity for the AIT
group was around 88% of peak HR and for the ACT group around 80%
of peak HR during the 12 week intervention (Supplemental Table 5).
Mean training workloads for the AIT group were 86% of peak workload
and for the ACT group 63% of peak workload (Supplemental Table 6).
There were signiﬁcant group differences between the training intensi-
ties (p-group b 0.001), the training workloads (p-group b 0.001) and
the Borg scores (p-group b 0.001; AIT: 13.5 ± 1.6 vs ACT: 12.5 ± 1.5),
with higher values for the AIT group.
No adverse events were reported during the training sessions.
One patient (ACT) had an AMI, N24 h after his last training session,
after which PCI was performed. Two other patients (both ACT) had a
signiﬁcant ST-depression during the exercise test at 6 weeks and
underwent PCI.
Table 1
Baseline characteristics of the participants.
Total group AIT ACT Signiﬁcance
Sample size 200 100 100
Characteristics
Gender (M/F) 180/20 91/9 89/11 NS
Age (years) 58.4 ± 9.1 57.0 ± 8.8 59.9 ± 9.2 P = 0.023
Height (cm) 173 ± 8.0 174 ± 7.6 173 ± 8.4 NS
Weight (kg) 84.9 ± 14.0 84.7 ± 14.4 85.0 ± 13.7 NS
BMI (kg/m2) 28.3 ± 4.3 28.0 ± 4.4 28.5 ± 4.3 NS
Waist (cm) 99.7 ± 11.7 100 ± 12.0 99.4 ± 11.6 NS
Peak VO2 (ml/kg/min) 22.7 ± 5.69 23.3 ± 5.78 22.2 ± 5.56 NS
FMD (%)a 5.62 ± 2.84 5.53 ± 3.15 5.71 ± 2.50 NS
Reason for referral
AMI 115 67 48 P = 0.007
PCI 25 7 18 P = 0.019
CABG 60 26 34 NS
Duration of CAD NS
≤3 months 156 83 73
N3 months 44 17 27
LVEF (%) 56.9 ± 8.1 57.1 ± 8.5 56.8 ± 7.7 NS
Cardiovascular risk factors
Hypertension 104 58 46 NS
Diabetes 38 20 18 NS
History of COPD 4 3 2 NS
Familial predisposition 50 21 29 NS
Smoking NS
Never 53 27 26
Ex 122 59 63
Current 25 14 11
Alcohol consumption
(drinks/week)
4.2 ± 5.7 4.7 ± 6.5 3.7 ± 4.7 NS
Medication
Beta-blockers 167 84 83 NS
Anti-hypertensive
medication
149 77 72 NS
Nitrates 9 5 4 NS
Diuretics 25 10 15 NS
Anti-arrhythmics 4 3 1 NS
ASA 188 93 95 NS
Anti-thrombotics 147 76 71 NS
Vitamin K antagonists 15 9 6 NS
Digitalis 2 1 1 NS
Statins 196 97 99 NS
Antidiabetic medication 37 18 19 NS
Data are expressed as means ± standard deviation (SD) for continuous variables or as
percentages for dichotomous variables.
AIT = aerobic interval training; ACT = aerobic continuous training; M = male;
F = female; NS = not signiﬁcant; BMI = body mass index; peak VO2 = peak oxygen up-
take; FMD = ﬂow-mediated dilation; AMI = acute myocardial infarction; PCI = -
percutaneous coronary intervention; CABG = coronary artery bypass grafting;
CAD = coronary artery disease; LVEF = left ventricular ejection fraction; COPD = chronic
obstructive pulmonary disease; ASA = acetylsalicylic acids.
a FMD data were available in 188 patients (AIT and ACT, n = 94).
Table 2
Peak exercise capacity parameters at baseline, after 6 and after 12 weeks of AIT or ACT.
AIT (n = 85)
Parameter 0 weeks 6 weeks 12 weeks 0 weeks
VO2 (ml/min) 1965 ± 503 2232 ± 548 2395 ± 560 1887 ± 47
VO2/kg (ml/kg/min) 23.5 ± 5.7 26.7 ± 6.7 28.6 ± 6.9 22.4 ± 5.6
HR (bpm) 134 ± 21.0 140 ± 19.0 145 ± 18.2 129 ± 21
Workload (Watt) 154 ± 38.8 177 ± 44.9 192 ± 46.9 145 ± 41
RER 1.26 ± 0.12 1.27 ± 0.12 1.28 ± 0.11 1.26 ± 0.1
O2 pulse 14.8 ± 3.6 16.0 ± 3.5 16.6 ± 3.5 14.7 ± 2.9
Data are expressed as means ± standard deviation (SD). All data are corrected for age and pat
AIT = aerobic interval training; ACT = aerobic continuous training; n = number of patients;
RER = respiratory exchange ratio; *p b 0.05; **p b 0.01; ***p b 0.001; §p = 0.068; a = 6 wee
c = 12 weeks differed signiﬁcantly from 6 weeks.
Fig. 3. Percent changes in peak VO2 in AIT and ACT after 6 and 12 weeks. Data are
means± SEM; * = signiﬁcantly different from baseline (p b 0.001); ** = 6 weeks differs
signiﬁcantly from 12 weeks (p = 0.0231); NS = not signiﬁcant; black bars = AIT; grey
bars = ACT.
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Exercise training is a cornerstone in cardiac rehabilitation; however,
there is still controversy regarding the exercise characteristics that are
most effective for improving peak VO2 in CAD patients [10]. Proof of
concept papers comparing AIT and MCT were conducted in small sam-
ple sizes and ﬁndings were inconsistent and heterogeneous [16]. The
results of the present large randomized multicentre study in CAD
patients demonstrate that AIT and ACT are equal in improving peak
VO2, peripheral endothelial function, QoL, and some cardiovascular risk
factors. In addition, both programmes seem to have beneﬁcial effects
within the ﬁrst 6 weeks of training and are safe in CAD patients.
Peak VO2 increased with 5.06 ± 4.06 ml/kg/min or 22.7 ± 17.6%
after AIT and with 4.35 ± 3.21 ml/kg/min or 20.3 ± 15.3% after ACT.
These increases are probably of clinical relevance, as suggested by a
large observational study, where each 3.5 ml/kg/min increment in
peak VO2 resulted in a 12% improvement in survival [7]. This 22.7% in-
crease in peak VO2 after AIT is comparable to the increments reported
in themeta-analysis of Pattyn et al. [16] (20.5%) and to other large inter-
vention studies [12,23], while the 20.3% increase after ACT in our study
is larger than the 12.8% increase in peak VO2 described in the same
meta-analysis [16]. The differencewith earlier publicationsmight be ex-
plained by the on average lower training intensity observed in these
ACT groups [16] (range 70–75% of peak HR) resulting in relatively
lower gains in peak VO2. Analyses of the present study showed that
our ACT group trained at average intensities of 80% of peak HR. The
fact that none of the patients had to terminate the exercise prematurelyACT (n = 89) F-values
6 weeks 12 weeks Time Group Interaction
3 2116 ± 527 2238 ± 550 31.69***,a,b,c 3.34§ 0.31NS
25.2 ± 6.2 26.8 ± 6.7 28.18***,a,b,c 3.87* 0.16NS
.1 134 ± 22.3 138 ± 21.5 12.84***,a,b 10.38** 0.13NS
.0 169 ± 47.9 180 ± 46.6 39.42***,a,b,c 3.98* 0.17NS
1 1.26 ± 0.09 1.27 ± 0.09 0.84NS 0.28NS 0.20NS
15.9 ± 3.3 16.2 ± 3.2 12.32***,a,b 0.04NS 0.07NS
hology.
VO2 = oxygen uptake; NS = not signiﬁcant; HR = heart rate; bpm = beats per minute;
ks differed signiﬁcantly from baseline; b = 12 weeks differed signiﬁcantly from baseline;
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ACT that if a higher intensity can be sustained, the workloads and HR
zones need to be adapted to achieve the best improvements possible.
In contrast, the average intensity of the AIT group was 88% of peak
HR, which is lower than the prescribed intensity. In practice, we had
to decrease training intensity in several patients in order to avoid ex-
treme hyperventilation or discontinuation of pedalling. In accordance
with our results, Guiraud et al. demonstrated that a shorter high-
intensity interval (15 s) was at least as efﬁcient in the time spent at
peak VO2 and much better tolerated than the longer ones (60 s) in
CAD patients [24]. However, our patients in the AIT group perceived
shortness of breath and scored signiﬁcantly higher on the Borg scale
than the ACT group. Though, we think that the results of the Borg
scale were not reliable and did not reﬂect real exercise intensity. This
is in agreement with a recently published paper [25], in which the au-
thors concluded that rating of perceived exertion results in an exercise
intensity below target (Borg score 17) during high-intensity interval
training bouts, and that HRmonitors should be used for accurate inten-
sity guidance.We can conclude that AIT training at 90–95%of peakHR is
hardly feasible inmost of the CAD patients, at least not for the full 4min.
Nevertheless, if we calculated the relative intensity of sessions
19–36 using peak HR1, patients in the AIT group trained at N90% of
peak HR1, as prescribed (Supplemental Table 5). Since peak HR
increased (Table 2) following training, target HR zones needed adapta-
tion. The relative intensity of sessions 19–36 was only 84% of peak HR3
(Supplemental Table 5), which suggests that not changing the target HR
zones result in low intensities of training andprobably smaller improve-
ments after the intervention.
Following these results and observations, we suggest that in clinical
practice, it is necessary to adjust the objectively deﬁned target HR zones
and workloads according to the patient's subjective feelings as [11]
1) ACT programmes can be sustained at intensities higher than 70–
75% of peak HR, and 2) AIT programmes with 4-minute intervals at
90–95%of peakHRare hardly feasible for 4min. Furtherwe recommend
an intermediate exercise test to adapt target HR zones.
Endothelial dysfunction is an important early precursor of athero-
sclerosis and is an independent predictor of cardiovascular events [26].
Previous studies have shown that FMD improves after exercise-based
cardiac rehabilitation in CAD patients [27–29]. In accordance to our re-
sults, Currie et al. [30] found similar improvements after AIT and MCT,
while Wisløff et al. [14] and Tjonna et al. [31] found larger increases
after AIT compared to MCT. At the moment, there is no consensus for
a clinical relevant cut off value for brachial artery FMD [32]. However,
it has been shown that persistent impairment of FMD, deﬁned as FMD
b5.5%, is an independent predictor of cardiovascular morbidity and
mortality in CAD patients [33]. The mean pre-training value for the
total group in our study was 5.44% (n = 156), which can be classiﬁed
as borderline impaired FMD and results in a 2.9 times higher risk of
cardiovascular events compared to an FMD N5.5% [33]. This implies
that the improvement in FMD to 6.58% is of clinical relevance. The endo-
thelial function increased signiﬁcantly during the ﬁrst 6 weeks of the
intervention, while further improvements were diminished between 6
and 12 weeks. It seems that endothelial function adapts fast followingTable 3
Endothelial function parameters at baseline, after 6 and after 12 weeks of AIT or ACT.
AIT (n = 76)
Parameter 0 weeks 6 weeks 12 weeks 0 weeks
Resting diameter (mm) 3.96 ± 0.56 4.00 ± 0.56 4.00 ± 0.50 3.93 ±
FMD (%) 5.26 ± 3.02 6.33 ± 3.22 6.47 ± 2.79 5.61 ±
NMD (%) 22.6 ± 6.57 22.5 ± 6.55 22.2 ± 7.19 22.1 ±
Data are expressed as means ± standard deviation (SD). All data are corrected for age and pat
AIT = aerobic interval training; ACT = aerobic continuous training; n = number of patients;
**p b 0.01; ***p b 0.001; a = 6 weeks differed signiﬁcantly from baseline; b = 12 weeks diffeexercise training, which conﬁrms the statement made in a review by
Green et al. [34].
The absolute change in FMD correlated inversely with baseline FMD
and positively with the increase in peak VO2. These ﬁndings were also
reported by Luk et al. [28] andWisløff et al. [14], and support theﬁnding
that endothelial function is a possible underlyingmechanism in the im-
provement of exercise capacity. Indeed, changes in peak VO2 following
exercise training result from increased O2 delivery (due to increased
stroke volume and exercise-induced vasodilation) and enhanced O2
consumption (increased oxidative capacity of skeletal muscles). We
observed no change in NMD following AIT or ACT, which is in line
with other studies [14,30]. It seems that exercise primarily corrects
the endothelial dysfunction and does not improve the vascular smooth
muscle cell responsiveness [28].
Self-perceived QoL increased signiﬁcantly and to a similar extent
after AIT and ACT. There is evidence that post-AMI patients have signif-
icant and clinically relevant poorer scores than healthy subjects [21,35].
Our CAD patients scored lower on the physical and mental component
compared to normative scores of the general Dutch population, even
after the training intervention [21]. Our patients showed similar PCS
scores [21] but lower MCS scores [21] compared to a large sample of
Dutch post-AMI patients. It seems reasonable to suggest that more
psychological support is necessary to normalize the self-perceived
mental health.
HDL-C improved signiﬁcantly in both groups, which is in contrast
with ﬁndings in meta-analyses on exercise training in CAD patients
[3,4] and other AIT versus MCT trials [36]. Total cholesterol, which con-
sists of HDL-C, LDL-C and very LDL-C, increased after the intervention,
probably caused by the signiﬁcant increment of HDL-C. Yet, the total/
HDL cholesterol ratio seems to be more informative about CAD mortal-
ity than total cholesterol or HDL-C either, with a lower ratio predicting
a lower mortality rate [37]. In our study, the ratio showed a non-
signiﬁcant decrease following the intervention. Hs-CRP decreased
after the intervention, which is in line with results of a meta-analysis
of Swardfager et al. who found a signiﬁcantly reduced inﬂammatory ac-
tivity after exercise training in CAD patients [38]. Other laboratory pa-
rameters did not change signiﬁcantly because most of the patients
were optimally treated with lipid-lowering medication and anti-
diabetic medication if necessary (see Table 1).
Finally, our results show that 6 weeks of three-weekly sessions of
38min (duration of oneAIT session) are already sufﬁcient to obtain clin-
ically relevant improvements in peak VO2, peripheral endothelial func-
tion and QoL. This is of interest to the patient as these observed
improvements might be an extra stimulus to continue a physically ac-
tive lifestyle. Furthermore we conﬁrm that a longer training period re-
sulted in further signiﬁcant increases in peak VO2, which stresses the
need of encouraging a life-long physically active lifestyle not only to fur-
ther improve but at least to maintain the obtained improvements [39].
4.1. Strengths and limitations
This study is strengthened by the large sample size (n = 200), the
repeated CPET after 6 weeks to adapt the training intensity, the objectiveACT (n = 84) F-values F-value
6 weeks 12 weeks Time Group Interaction
0.56 3.95 ± 0.58 3.99 ± 0.65 0.32NS 0.11NS 0.04NS
2.36 6.46 ± 2.87 6.68 ± 3.09 7.28***,a,b 1.69NS 0.06NS
7.30 21.2 ± 7.77 22.1 ± 6.92 0.21NS 0.40NS 0.28NS
hology. Data for FMD are corrected for age, pathology and centre of enrolment.
NS = not signiﬁcant; FMD = ﬂow-mediated dilation; NMD = nitrate-mediated dilation;
red signiﬁcantly from baseline.
Table 4
Cardiovascular risk factors and quality of life at baseline and after 12 weeks of AIT or ACT.
AIT (n = 85) ACT (n = 89) F-values
Parameter 0 weeks 12 weeks 0 weeks 12 weeks Time Group Interaction
Weight (kg) 84.6 ± 14.5 85.1 ± 14.2 85.1 ± 13.9 84.6 ± 13.4 0.00NS 0.13NS 0.07NS
BMI (kg/m2) 27.9 ± 4.1 28.0 ± 3.9 28.5 ± 4.3 28.2 ± 4.2 0.01NS 0.92NS 0.11NS
Waist (cm) 99.7 ± 11.7 98.8 ± 11.5 99.5 ± 11.3 97.6 ± 10.9 1.66NS 0.34NS 0.15NS
Resting HR 57.7 ± 7.9 55.4 ± 7.4 59.4 ± 10.5 55.4 ± 8.1 6.48** 0.01NS 0.80NS
SBP (mm Hg) 125 ± 14.3 125 ± 14.3 128 ± 17.2 122 ± 13.3 2.45$ 0.85NS 2.18NS
DBP (mm Hg) 75.8 ± 8.4 74.7 ± 8.4 76.2 ± 10.6 72.5 ± 8.2 3.08* 1.08NS 0.83NS
Fasting glucose (mmol/l) 5.40 ± 1.04 5.59 ± 1.42 5.29 ± 0.81 5.47 ± 1.32 2.20NS 2.49NS 0.00NS
Cholesterol (mmol/l) 3.61 ± 0.71 3.78 ± 0.74 3.60 ± 0.78 3.76 ± 0.78 4.36* 1.20NS 0.01NS
HDL-C (mmol/l) 1.13 ± 0.27 1.21 ± 0.26 1.11 ± 0.28 1.20 ± 0.31 9.25** 2.63NS 0.10NS
Cholesterol/HDL-C ratio 3.33 ± 0.96 3.23 ± 0.85 3.41 ± 0.96 3.27 ± 0.89 1.38NS 0.92NS 0.03NS
LDL-C (mmol/l) 1.88 ± 0.51 1.97 ± 0.53 1.98 ± 0.66 2.05 ± 0.66 1.57NS 0.55NS 0.01NS
Triglycerides (mmol/l) 1.49 ± 0.99 1.47 ± 0.90 1.28 ± 0.49 1.25 ± 0.47 0.09NS 4.42* 0.00NS
hs-CRP (log mg/l)§ 0.21 ± 0.44 0.12 ± 0.52 0.24 ± 0.57 0.07 ± 0.52 5.67* 0.20NS 0.51NS
QoL Physical component 43.5 ± 8.1 47.7 ± 7.5 42.4 ± 7.7 46.8 ± 6.1 14.62*** 0.35NS 0.74NS
QoL Mental component 36.1 ± 7.8 38.6 ± 7.7 35.8 ± 7.5 38.8 ± 5.7 7.98*** 0.05NS 0.15NS
Data are expressed as means ± standard deviation (SD). All data are corrected for age and pathology.
AIT = aerobic interval training; ACT = aerobic continuous training; n = number of patients; NS = not signiﬁcant; BMI = bodymass index; HR = heart rate; bpm = beats perminute;
SBP = systolic bloodpressure;DBP = diastolic blood pressure;HDL-C = highdensity lipoprotein cholesterol; LDL-C = lowdensity lipoprotein cholesterol; hs-CRP = high sensitivity C-
reactive protein; QoL = quality of life (AIT n = 76, ACT n = 83); *p b 0.05; **p b 0.01; ***p b 0.001; $p = 0.066; §data for hs-CRP were log transformed.
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ing the training sessions, and the multicentre design. Yet, multicentre
studies have limitations including the variability in assessments, analyses,
and implementation of training between the centres. In addition, caloric
expenditurewasnotmeasured,which could have beenuseful to compare
the efﬁciency of the programmes. Flow-mediated dilation differed signif-
icantly between the centres (p b 0.001) and was therefore corrected in
the analysis. Another limitation is the larger participation rate of men
compared to women, and moreover a larger drop-out in women.
4.2. Future research
Future researchmust focus on 1) the comparison of AIT andACT per-
formed at representative and feasible intensities, 2) the underlying
mechanisms responsible for peak VO2 improvements, 3) the measure-
ment of caloric expenditure of AIT and ACT or MCT used in the present
and in previous studies, and 4) the comparison of AIT and ACT protocols
with other cardiac rehabilitation programmes in terms of training
response, long-term health, QoL and patient satisfaction.
5. Conclusion
We can conclude that a 12-week AIT and ACT intervention equally
improve peak VO2, peripheral endothelial function, QoL and some car-
diovascular risk factors in CAD patients. In addition, both programmes
seem to be safe for CAD patients. In our experience, sustained AIT at
90–95% of peak HR during 4 min is hardly feasible in CAD patients.
When using continuous exercise training, a sufﬁcient training intensity
should be performed, which may be more than the 70–75% of peak HR
of the baseline evaluation as used in a number of previous studies. These
conclusions should be taken into account when prescribing exercise
training programmes in clinical practice.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcard.2014.10.155.
Potential conﬂicts of interest
There are no conﬂicts of interests to declare.
Acknowledgements
This work was funded by the Agency of Innovation by Science and
Technology (IWT-project number 090870). VMC was supported by Re-
search Foundation Flanders (FWO) as a clinical postdoctoral fellow, andVAC is supported by Research Foundation Flanders (FWO) as a postdoc-
toral fellow. EVC is supported by Research Foundation Flanders (FWO)
as a senior clinical investigator. LV is the holder of the faculty chair
‘Lifestyle and Health’ at the University of Applied Sciences, Utrecht,
the Netherlands. We want to thank Prof. V. Van Hoof, head of the
Department of Clinical Biology of the University Hospital of Antwerp,
for the cooperation. In addition, we want to thank Inge Goovaerts, Guy
Ennekens and Katrijn Van Ackeren for the performance and analyses
of the endothelial function measurements in the University Hospital of
Antwerp. Our thanks also go to Yvette Piccart and Tamara Coenen for
the processing of the blood samples in the University Hospital of
Leuven.References
[1] R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, et al., Global and
regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a
systematic analysis for the Global Burden of Disease Study 2010, Lancet 380 (9859)
(2012) 2095–2128.
[2] M. Nichols, N. Townsend, R. Luengo-Fernandez, J. Leal, A. Gray, P. Scarborough, M.
Reyner, European Cardiovascular disease statistics, European heart network,
European Society of Cardiology, Brussels, 2012.
[3] R.S. Taylor, A. Brown, S. Ebrahim, J. Jolliffe, H. Noorani, K. Rees, Exercise-based
rehabilitation for patients with coronary heart disease: systematic review and
meta-analysis of randomized controlled trials, Am. J. Med. 116 (10) (2004)
682–692.
[4] N. Oldridge, Exercise-based rehabilitation in patients with coronary heart disease:
meta-analysis outcomes revisited, Futur. Cardiol. 8 (5) (2012) 729–751.
[5] C.W. Shepherd, A.E. While, Cardiac rehabilitation and quality of life: a systematic
review, Int. J. Nurs. Stud. 49 (6) (2012) 755–771.
[6] L. Vanhees, R. Fagard, L. Thijs, A. Amery, Prognostic value of training-induced change
in peak exercise capacity in patients with myocardial infarcts and patients with
coronary bypass surgery, Am. J. Cardiol. 76 (14) (1995) 1014–1019.
[7] J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, J.E. Atwood, Exercise capacity
and mortality among men referred for exercise testing, N. Engl. J. Med. 346 (11)
(2002) 793–801.
[8] T. Kavanagh, D.J. Mertens, L.F. Hamm, J. Beyene, J. Kennedy, P. Corey, R.J. Shephard,
Prediction of long-term prognosis in 12169 men referred for cardiac rehabilitation,
Circulation 106 (6) (2002) 666–671.
[9] S.J. Keteyian, C.A. Brawner, P.D. Savage, J.K. Ehrman, J. Schairer, G. Divine, H. Aldred,
K. Ophaug, P.A. Ades, Peak aerobic capacity predicts prognosis in patients with
coronary heart disease, Am. Heart J. 156 (2) (2008) 292–300.
[10] L. Vanhees, B. Rauch, M. Piepoli, F. van Buuren, T. Takken, M. Börjesson, et al.,
Writing group EACPR. Importance of characteristics and modalities of physical ac-
tivity and exercise in the management of cardiovascular health in individuals
with cardiovascular disease (part III), Eur. J. Prev. Cardiol. 19 (6) (2012) 1333–1356.
[11] A. Mezzani, L.F. Hamm, A.M. Jones, P.E. McBride, T. Moholdt, J.A. Stone, et al., Aerobic
exercise intensity assessment and prescription in cardiac rehabilitation: a joint
position statement of the European Association for Cardiovascular Prevention and
Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabil-
itation and the Canadian Association of Cardiac Rehabilitation, Eur. J. Prev. Cardiol.
20 (3) (2013) 442–467.
210 V.M. Conraads et al. / International Journal of Cardiology 179 (2015) 203–210[12] L. Vanhees, A. Stevens, D. Schepers, J. Defoor, F. Rademakers, R. Fagard, Determinants
of the effects of physical training and of the complications requiring resuscitation
during exercise in patients with cardiovascular disease, Eur. J. Cardiovasc. Prev.
Rehabil. 11 (4) (2004) 304–312.
[13] A.J. Rankin, A.C. Rankin, P. MacIntyre, W.S. Hillis, Walk or run? Is high-intensity ex-
ercise more effective than moderate-intensity exercise at reducing cardiovascular
risk? Scott. Med. J. 57 (2) (2012) 99–102.
[14] U. Wisløff, A. Støylen, J.P. Loennechen, M. Bruvold, Ø. Rognmo, P.M. Haram, A.E.
Tjønna, J. Helgerud, S.A. Slørdahl, S.J. Lee, V. Videm, A. Bye, G.L. Smith, S.M. Najjar,
Ø. Ellingsen, T. Skjaerpe, Superior cardiovascular effect of aerobic interval training
versus moderate continuous training in heart failure patients: a randomized
study, Circulation 115 (24) (2007) 3086–3094.
[15] S.J. Keteyian, B.A. Hibner, K. Bronsteen, D. Kerrigan, H.A. Aldred, L.M. Reasons, M.A.
Saval, C.A. Brawner, J.R. Schairer, T.M. Thompson, J. Hill, D. McCulloch, J.K. Ehrman,
Greater improvement in cardiorespiratory ﬁtness using higher-intensity interval
training in the standard cardiac rehabilitation setting, J. Cardiopulm. Rehabil. Prev.
34 (2) (2014) 98–105.
[16] N. Pattyn, E. Coeckelberghs, R. Buys, V.A. Cornelissen, L. Vanhees, Aerobic interval
training vs. moderate continuous training in coronary artery disease patients: a
systematic review and meta-analysis, Sports Med. 44 (5) (2014) 687–700.
[17] V.M. Conraads, E.M. Van Craenenbroeck, N. Pattyn, V.A. Cornelissen, P.J. Beckers, E.
Coeckelberghs, C. De Maeyer, J. Denollet, G. Frederix, K. Goetschalckx, V.Y.
Hoymans, N. Possemiers, D. Schepers, B. Shivalkar, L. Vanhees, Rationale and design
of a randomized trial on the effectiveness of aerobic interval training in patients
with coronary artery disease: the SAINTEX-CAD study, Int. J. Cardiol. 168 (4)
(2013) 3532–3536.
[18] J.R. Williams, The declaration of Helsinki and public health, Bull. World Health
Organ. 86 (8) (2008) 650–652.
[19] M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A.
Creager, et al., Guidelines for the ultrasound assessment of endothelial-dependent
ﬂow-mediated vasodilation of the brachial artery: a report of the International
Brachial Artery Reactivity Task Force, J. Am. Coll. Cardiol. 39 (2) (2002) 257–265.
[20] J. Ware Jr., M. Kosinski, S.D. Keller, A 12-item short-form health survey: construction
of scales and preliminary tests of reliability and validity, Med. Care 34 (3) (1996)
220–233.
[21] F. Mols, A.J. Pelle, N. Kupper, Normative data of the SF-12 health survey with valida-
tion using post-myocardial infarction patients in the Dutch population, Qual. Life
Res. 18 (4) (2009) 403–414.
[22] Intention to treat analysis and per protocol analysis: complementary information,
Prescrire Int. 21 (133) (2012) 304–306.
[23] American College of Sports Medicine Position Stand. Exercise for patients with
coronary artery disease, Med. Sci. Sports Exerc. 26 (3) (1994) i–v.
[24] T. Guiraud, M. Juneau, A. Nigam, M. Gayda, P. Meyer, S. Mekary, F. Paillard, L.
Bosquet, Optimization of high intensity interval exercise in coronary heart disease,
Eur. J. Appl. Physiol. 108 (4) (2010) 733–740.
[25] I.L. Aamot, S.H. Forbord, T. Karlsen, A. Støylen, Does rating of perceived exertion re-
sult in target exercise intensity during interval training in cardiac rehabilitation? A
study of the Borg scale versus a heart rate monitor, J. Sci. Med. Sport 17 (5)
(2014) 541–545.[26] S. Erbs, A. Linke, R. Hambrecht, Effects of exercise training on mortality in patients
with coronary heart disease, Coron. Artery Dis. 17 (3) (2006) 219–225.
[27] D.G. Edwards, R.S. Schoﬁeld, S.L. Lennon, G.L. Pierce, W.W. Nichols, R.W. Braith,
Effect of exercise training on endothelial function in men with coronary artery
disease, Am. J. Cardiol. 93 (5) (2004) 617–620.
[28] T.H. Luk, Y.L. Dai, C.W. Siu, K.H. Yiu, H.T. Chan, S.W. Lee, S.W. Li, B. Fong, W.K. Wong,
S. Tam, C.P. Lau, H.F. Tse, Effect of exercise training on vascular endothelial function
in patients with stable coronary artery disease: a randomized controlled trial, Eur. J.
Prev. Cardiol. 19 (4) (2012) 830–839.
[29] V.A. Cornelissen, S. Onkelinx, K. Goetschalckx, T. Thomaes, S. Janssens, R. Fagard, P.
Verhamme, L. Vanhees, Exercise-based cardiac rehabilitation improves endothelial
function assessed by ﬂow-mediated dilation but not by pulse amplitude tonometry,
Eur. J. Prev. Cardiol. 21 (1) (2014) 39–48.
[30] K.D. Currie, J.B. Dubberley, R.S. McKelvie, M.J. MacDonald, Low-volume, high-
intensity interval training in patients with CAD, Med. Sci. Sports Exerc. 45 (8)
(2013) 1436–1442.
[31] A.E. Tjonna, S.J. Lee, Ø. Rognmo, T.O. Stølen, A. Bye, P.M. Haram, J.P. Loennechen, Q.Y.
Al-Share, E. Skogvoll, S.A. Slørdahl, O.J. Kemi, S.M. Najjar, U. Wisløff, Aerobic interval
training versus continuous moderate exercise as a treatment for the metabolic syn-
drome: a pilot study, Circulation 118 (4) (2008) 346–354.
[32] D.H. Thijssen, M.A. Black, K.E. Pyke, J. Padilla, G. Atkinson, R.A. Harris, B. Parker, M.E.
Widlansky, M.E. Tschakovsky, D.J. Green, Assessment of ﬂow-mediated dilation in
humans: a methodological and physiological guideline, Am. J. Physiol. Heart Circ.
Physiol. 300 (1) (2011) H2–H12.
[33] Y. Kitta, J.E. Obata, T. Nakamura, M. Hirano, Y. Kodama, D. Fujioka, Y. Saito, K.
Kawabata, K. Sano, T. Kobayashi, T. Yano, K. Nakamura, K. Kugiyama, Persistent im-
pairment of endothelial vasomotor function has a negative impact on outcome in
patients with coronary artery disease, J. Am. Coll. Cardiol. 53 (4) (2009) 323–330.
[34] D.J. Green, A. Maiorana, G. O'Driscoll, R. Taylor, Effect of exercise training on
endothelium-derived nitric oxide function in humans, J. Physiol. 561 (1) (2004)
1–25.
[35] J.G. Crilley, M. Farrer, Impact of ﬁrst myocardial infarction on self-perceived health
status, QJM 94 (1) (2001) 13–18.
[36] T.T. Moholdt, B.H. Amundsen, L.A. Rustad, A.Wahba, K.T. Løvø, L.R. Gullikstad, A. Bye,
E. Skogvoll, U. Wisløff, S.A. Slørdahl, Aerobic interval training versus continuous
moderate exercise after coronary artery bypass surgery: a randomized study of
cardiovascular effects and quality of life, Am. Heart J. 158 (6) (2009) 1031–1037.
[37] Prospective Studies CollaborationS. Lewington, G. Whitlock, R. Clarke, P. Sherliker, J.
Emberson, et al., Blood cholesterol and vascular mortality by age, sex, and blood
pressure: a meta-analysis of individual data from 61 prospective studies with
55,000 vascular deaths, Lancet 370 (9602) (2007) 1829–1839.
[38] W. Swardfager, N. Herrmann, S. Cornish, G. Mazereeuw, S. Marzolini, L. Sham, K.L.
Lanctôt, Exercise intervention and inﬂammatory markers in coronary artery
disease: a meta-analysis, Am. Heart J. 163 (4) (2012) 666–667.
[39] D. Hansen, P. Dendale, L.J. van Loon, R. Meeusen, The impact of training modalities
on the clinical beneﬁts of exercise intervention in patients with cardiovascular
disease risk or type 2 diabetes mellitus, Sports Med. 40 (11) (2010) 921–940.
